Koshimizu, Taka-Aki <br/><br/>
Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.  [electronic resource] 

 -  Cardiovascular research  Sep 2004 
 - 662-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-6363 
<br/><br/><label>Standard No.: </label>10.1016/j.cardiores.2004.05.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Antagonists--pharmacology<br/>Calcium--metabolism<br/>Carbazoles--pharmacology<br/>Carvedilol<br/>Cell Line<br/>Humans<br/>Kidney--embryology<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Norepinephrine--pharmacology<br/>Phenylephrine--pharmacology<br/>Propanolamines--pharmacology<br/>Protein Binding<br/>Receptors, Adrenergic, alpha-1--metabolism<br/>Receptors, Adrenergic, beta--metabolism<br/>Stimulation, Chemical